首页 > 市场调查报告书 > 製药

疫苗

市场调查报告书

商品编码

1378598

冠状病毒疫苗市场：依疫苗类型、配销通路和地区划分

Coronavirus Vaccine Market, By Vaccine Type, By Distribution Channel, By Geography

出版日期: 2023年10月13日 | 出版商:

Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计2023年全球冠状病毒疫苗市场规模为439亿美元，预测期内（2023-2030年）年复合成长率为7.4%。

报告范围		报告详情
基准年	2022年	2023年市场规模	439亿美元
实绩资料	2018-2021	预测期	2023-2030
预测期年复合成长率	7.40%	2030年市场规模预测	723亿美元

图 1. 2023 年冠状病毒疫苗的全球市场占有率（按疫苗类型划分）

冠状病毒感染疾病（COVID-19）是由 SARS-CoV-2 病毒引起的感染疾病。它具有高度传染性，传播迅速，并导致轻度至中度呼吸道疾病。疫苗生产和研发基本上涉及灭活疫苗、减毒疫苗、病毒载体疫苗等「全微生物疫苗」、病毒蛋白和糖亚基组成的「亚单位疫苗」以及病毒DNA和RNA遗传物质疫苗三类。根据世界卫生组织（WHO）公布的资料，截至2023年1月，有183种冠状病毒疫苗处于临床开发阶段，199种处于临床前开发阶段。疫苗接种是遏制全球冠状病毒病例数量不断上升的最佳方法。 COVID-19 病例的增加预计将在预测期内支持市场成长。例如，根据世界卫生组织 (WHO) 冠状病毒 (COVID-19) 每週流行病学更新，截至 2021 年 5 月 30 日，全球冠状病毒 (COVID-19) 病例超过 1.69 亿例，其中 350 例。据报道，死亡人数超过10,000 人。主要企业积极参与增加研发活动和临床试验，预计将推动全球冠状病毒疫苗市场的成长。

市场动态

疫苗行业的主要参与者专注于开发新疫苗。此外，政府增加投资以支持 COVID-19 疫苗的生产和分销预计将推动市场成长。例如，2023 年 9 月 13 日，美国美国管制与预防中心 (CDC) 建议为 6 个月及以上的人接种新的 COVID 疫苗。政府推出此类法规预计将在预测期内推动全球冠状病毒疫苗市场的成长。

本研究的主要特点

本报告详细分析了全球冠状病毒疫苗市场，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和复合年度（年复合成长率）。
它还阐明了各个细分市场的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
它根据公司亮点、产品系列、主要亮点、业绩和策略等参数，介绍了全球冠状病毒疫苗市场的主要企业。
该报告的见解使行销人员和公司负责人能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的资讯。
全球冠状病毒疫苗市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过用于分析全球冠状病毒疫苗市场的各种策略矩阵来促进决策。

公司简介
- Pfizer-BioNtech
- AstraZeneca
- Bharat Biotech
- Johnson &Johnson Services, Inc
- Moderna, Inc.
- Sinovac Biotech Ltd.
- Serum Institute of India Pvt. Ltd.
- Sanofi SA
- Novavax, Inc.
- Symvivo
- CanSinoBIO
- CureVac AG
- Zydus Cadila
- Arcturus Therapeutics Holdings Inc.
- Entos Pharmaceuticals

第9章章节

参考
调查方法

简介目录

Product Code: CMI4320

Global Coronavirus Vaccine Market is estimated to be valued at US$ 43.9 Bn in 2023, and is expected to exhibit a CAGR of 7.4% during the forecast period (2023-2030).

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 43.9 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	7.40%	2030 Value Projection:	US$ 72.3 Bn

Figure 1. Global Coronavirus Vaccine Market Share (%), By Vaccine Type, 2023

Coronavirus disease (COVID-19) is an infectious disease that is caused by the SARS-CoV-2 virus. It is contagious and spreads quickly, and causes mild to moderate respiratory illness. The manufacturing and development of vaccine are basically of three types the whole-microbe vaccine approach which has inactivated vaccine, live-attenuated vaccine, and viral vector vaccine; the sub-unit approach which consists of protein or sugar subunit of a virus and genetic material approach vaccine that has dna or RNA of the virus. According to the data published by World Health Organization(WHO), in January, 2023, 183 corona virus vaccine are in clinical development and 199 are in pre clinical development. Vaccination is the best method to control the rising cases of coronavirus cases across the globe. The increasing number of COVID-19 cases is expected to support growth of the market over the forecast period. For instance, according to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 169 million cases and 3.5 million deaths due to coronavirus (COVID-19) were reported up till May 30, 2021 globally. Key players are actively involved in increasing their research and development activities and clinical trials, and this is expected to drive the global coronavirus vaccine market growth.

Market Dynamics

Key players in the vaccine industry are focusing on the development of new vaccines. Moreover, increasing investments by government to support manufacturing and distribution of COVID-19 vaccines is expected to propel the market growth. For instance, on September 13, 2023, Centers for Disease Control and Prevention (CDC) recommended any one six months and older to get the new dose of COVID vaccine. Introduction of such regulations by government is expected to drive growth of the global coronavirus vaccine market over the forecast period.

Key features of the study:

This report provides an in-depth analysis of the global coronavirus vaccine market and provides market size (US$ Bn) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global coronavirus vaccine market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Pfizer-BioNtech, AstraZeneca, Bharat Biotech, Johnson & Johnson Services, Inc, Moderna, Inc., Sinovac Biotech Ltd., Serum Institute of India Pvt. Ltd., Sanofi S.A., Novavax, Inc., Symvivo, CanSinoBIO, CureVac AG, Zydus Cadila, Arcturus Therapeutics Holdings Inc., and Entos Pharmaceuticals
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global coronavirus vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global coronavirus vaccine market

Global Coronavirus Vaccine Market Detailed Segmentation:

By Vaccine Type:
- Inactivated Virus
- Protein Subunit
- Non-replicating Viral Vector
- Repurposed Vaccines
- RNA Vaccine
- DNA Vaccine
By Distribution Channel:
- Government Channel
- Hospital and Clinics
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Company Profiles
- Pfizer-BioNtech
- AstraZeneca
- Bharat Biotech.
- Johnson & Johnson Services, Inc
- Moderna, Inc.
- Sinovac Biotech Ltd.
- Serum Institute of India Pvt. Ltd.
- Sanofi S.A.,
- Novavax, Inc.
- Symvivo
- CanSinoBIO
- CureVac AG
- Zydus Cadila
- Arcturus Therapeutics Holdings Inc.
- Entos Pharmaceuticals

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Vaccine Type
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Coronavirus Vaccine Market- COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Coronavirus Vaccine Market, By Vaccine Type, 2018- 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Inactivated Virus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Protein Subunit
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Non-replicating Viral Vector
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Repurposed Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
RNA Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
DNA Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

6. Global Coronavirus Vaccine Market, By Distribution Channel, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Government Channel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Hospital and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)

7. Global Coronavirus Vaccine Market, By Region, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018 -2030, (US$ Bn)
North Africa
Central Africa
South Africa

8. Competitive Landscape

Company Profiles
- Pfizer-BioNtech
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- AstraZeneca
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Bharat Biotech
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Johnson & Johnson Services, Inc
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Moderna, Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Sinovac Biotech Ltd.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Serum Institute of India Pvt. Ltd.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Sanofi S.A.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Novavax, Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Symvivo
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- CanSinoBIO
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- CureVac AG
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Zydus Cadila
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Arcturus Therapeutics Holdings Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Entos Pharmaceuticals
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies

9. Section

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

冠状病毒疫苗市场：依疫苗类型、配销通路和地区划分

Coronavirus Vaccine Market, By Vaccine Type, By Distribution Channel, By Geography

市场动态

本研究的主要特点

目录

第1章调查目的和假设

第2章市场展望

第3章市场动态、法规及趋势分析

第4章全球冠状病毒疫苗市场-COVID-19疾病的影响分析

第5章全球冠状病毒疫苗市场，依疫苗类型，2018-2030

第6章全球冠状病毒疫苗市场，依配销通路，2018-2030

第7章2018-2030 年全球冠状病毒疫苗市场（按地区）

第8章竞争形势